DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Satoreotide trizoxetan

Generic Name: Satoreotide trizoxetan

Drug Type: Small Molecule

Chemical Formula: C_₇₃H_₉₅ClN_₁₈O_₂₁S_₂

CAS Number: 1638746-88-9

Unique Ingredient Identifier: 3M7TX701A4

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)

Phase 1

Terminated

Posted: 2018/12/12

Sponsor:Ipsen

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Phase 2

Terminated

Posted: 2018/10/05

Sponsor:Ipsen

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Phase 1

Completed

Posted: 2014/06/12

Sponsor:Ipsen

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy